FR EN

Update of The Pioneer Project : 400 patients in the biomarker program, 58 patients in the umbrella clinical trial

Date : 31 May 2022
Category : MI Live,News,Pioneer Project


As of May 31th, 2022, 17 partner centers are recruiting patients for the biomarker component of The Pioneer Project:

Hôpital Nord/AP-HM, Hôpital Européen and Hôpital Saint Joseph (Marseille), Hôpital Larrey/Oncopôle (Toulouse), Centre Léon Bérard (Lyon), Hôpital Sainte Musse (Toulon), Centre Hospitalier d’Annecy, Centre Hospitalier Vallées de l’Ariège (Foix), Hôpital Nord-Ouest (Villefranche-sur- Saône), Centre Hospitalier Henri Duffaut  (Avignon), Centre Hospitalier de Cahors, Centre Hospitalier du Pays d’Aix (Aix-en-Provence), Centre Hospitalier de Montauban, Centre Hospitalier de Bastia, Clinique Maymard (Bastia), ONCOGARD Nîmes and Alès.

Despite the difficult context of the COVID-19 pandemic, 453 patients have been screened, of which 400 have entered the biomarker component of the project (88,9%  of total inclusions). In parallel, 83 patients have been screened for and 58 have entered the PIONeeR umbrella clinical trial (48,3% of total inclusions).

PIONeeR BIOMARKERS

Centre

Number of patients screened

Number of patients included

CHU Marseille - Hopital Nord

205

181

ONCOPOLE Toulouse

28

25

CLB Lyon

31

24

Bastia Maymard

4

3

Hôpital Européen - Marseille

12

12

Hôpital Saint Joseph - Marseille

39

35

CH Toulon

37

33

CH Aix Pertuis

21

21

CH Bastia

3

3

CH Avignon

15

10

CHU Nimes

15

13

ONCOGARD

10

10

Cahors

3

3

CHIVA

9

7

Montauban

3

3

Annecy

5

4

Villefranche /S

13

13

Total

453

400

PIONeeR TRIAL

Centre

Number of patients screened

Number of patients included

CHU Marseille

58

39

CHU Toulouse

13

10

CLC Léon Bérard

12

9

Total

83

58

 


Back